VTRS FY 2014 Earnings — Viatris Inc. Revenue & Financial Results | Market Cap Arena

VTRSViatris Inc.

$16B

FY 2014 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$7.7B+11.7% YoY

Gross Profit

$3.5B45.7% margin

Operating Income

$1.4B17.5% margin

Net Income

$929M12.0% margin

EPS (Diluted)

$2.34

Cash Flow

Operating Cash Flow

$1.0B

Free Cash Flow

$690M

Stock-Based Comp.

$66M

Balance Sheet

Total Assets

$15.8B

Total Liabilities

$12.5B

Stockholders' Equity

$3.3B

Cash & Equivalents

$226M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$7.7B	$6.9B	+11.7%
Gross Profit	$3.5B	$3.0B	+16.0%
Operating Income	$1.4B	$1.1B	+19.1%
Net Income	$929M	$624M	+49.0%